Washington: Taking aspirin at least once per month is linked to a significant decrease in pancreatic cancer risk, according to a new study.Xiang-Lin Tan, a research fellow at Mayo Clinic in Rochester, Minn., said the findings from this large collaborative study are preliminary and do not encourage widespread use of aspirin for this purpose.
The researchers did not see a benefit from non-aspirin NSAIDs or acetaminophen. "This provides additional evidence that aspirin may have chemoprevention activity against pancreatic cancer," said Tan. He added that more data must be gathered before we can prove a real benefit.The study has been presented at the AACR 102nd Annual Meeting 2011, held here April 2-6. ANI
Complete analysis of Modi govt`s maiden budget
Budget growth oriented, says Arun Jaitley
Acting legend Zohra Sehgal dies at 102
We didn`t want to burden the common man: Arun Jaitley on budget